Victory Capital Management Inc. raised its holdings in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 519.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 223,941 shares of the company's stock after buying an additional 187,780 shares during the quarter. Victory Capital Management Inc. owned 0.21% of Definitive Healthcare worth $647,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DH. Bayesian Capital Management LP acquired a new stake in Definitive Healthcare in the 4th quarter valued at $41,000. KLP Kapitalforvaltning AS acquired a new stake in Definitive Healthcare in the 4th quarter valued at $54,000. Two Sigma Securities LLC acquired a new stake in Definitive Healthcare in the 4th quarter valued at $56,000. Cerity Partners LLC acquired a new stake in Definitive Healthcare in the 1st quarter valued at $56,000. Finally, ProShare Advisors LLC boosted its stake in Definitive Healthcare by 49.1% in the 4th quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock valued at $62,000 after buying an additional 4,943 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company's stock.
Wall Street Analyst Weigh In
DH has been the subject of a number of recent research reports. The Goldman Sachs Group boosted their target price on Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. Wall Street Zen upgraded Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. Finally, BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $4.77.
View Our Latest Analysis on DH
Definitive Healthcare Price Performance
Shares of DH stock traded up $0.03 during trading hours on Wednesday, reaching $3.91. The company's stock had a trading volume of 251,179 shares, compared to its average volume of 842,558. The firm's 50 day simple moving average is $3.85 and its 200-day simple moving average is $3.62. The company has a market capitalization of $580.44 million, a price-to-earnings ratio of -0.89, a PEG ratio of 6.46 and a beta of 1.64. Definitive Healthcare Corp. has a fifty-two week low of $2.15 and a fifty-two week high of $5.68. The company has a quick ratio of 1.75, a current ratio of 1.75 and a debt-to-equity ratio of 0.37.
Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. The company had revenue of $59.19 million during the quarter, compared to analysts' expectations of $56.20 million. During the same period in the prior year, the company earned $0.08 EPS. Definitive Healthcare's revenue was down 6.8% compared to the same quarter last year. Sell-side analysts forecast that Definitive Healthcare Corp. will post 0.16 earnings per share for the current year.
Definitive Healthcare Company Profile
(
Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Further Reading
Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access